Reportstack is one of the largest online libraries of market research publications. We are the fastest growing and most preferred provider of business intelligence in the market today. We partner with the world's top publishers and research houses to bring to you expert analysis, accurate data and market information along with the best customer support and user experience. For more details, please visit www.reportstack.com
Saturday, 1 April 2017
Detailed Report on Natural Killer Cells Therapies, 2017
Natural Killer Cells Therapies- Competitive Landscape,Technology and Pipeline Analysis, 2017 is a new market research publication announced by Reportstack. This report emphasizes on the currently active NK cell therapy products and NK cell augmenters in research and development.
The report covers 20+ companies, which are active in this field with 40+ products and many different technologies. This report covers NK cell based therapies and drugs that augment (enhance or activate) the NK cells. The report provides in-depth analysis on the Natural Killer Cell based therapies profiles along with the augmenting therapies covering their pre-clinical and clinical studies, collaborations details and deal values, technologies and targeted antigens. The report provides the NK Cell based therapies licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis.
Reports Highlights:NK cell Therapy Pipeline scenario which includes NK cell therapies and NK cell augmenting therapies. Collaborations & partnering deals Current Prominent Research Areas and Key Players Pipeline product profiles NK Cell therapy Technologies and NK cell Augmenting Therapies Licensing opportunities Market Drivers and Barriers
Scope Overview of the global NK cell therapy and NK cell augmenting therapies pipeline scenario, products and associated companies information Coverage of global NK cell therapies and drugs that enhance the activity of NK under development Competitive landscape of products for key players and related indications Coverage of licensors, collaborators and development partners, deal terms and deal values estimation Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities Highlights of licensing & collaboration opportunities and funding details Highlights of latest NK cell therapy technologies and NK cell augmenting therapies and innovative companies Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis